Can Proliferation Signal Inhibitor-Induced Tregs Really Reflect Transplantation Tolerance in Clinical Solid Organ Transplantation?

REFERENCES

• Lopez M. M., Valenzuela J. E., Alvarez F. C., López-Alvarez M. R., Cecilia G. S., Paricio P. P. Long-term problems related to immunosuppression. Transpl Immunol 2006; 17: 31–35
   PubMed Web of Science ®Google Scholar
• Shevach E. M. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002; 2: 389–400
   PubMed Web of Science ®Google Scholar
• Belkaid Y., Rouse B. T. Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6: 353–360
   PubMed Web of Science ®Google Scholar
• Wood K. J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199–210
   PubMed Web of Science ®Google Scholar
• Nishizuka Y., Sakakura T. Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969; 166: 753–755
   PubMed Web of Science ®Google Scholar
• Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α -chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151–1164
   PubMed Web of Science ®Google Scholar
• Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057–1061
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Gavin M. A., Rudensky A. Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 2003; 4: 330–336
   PubMed Web of Science ®Google Scholar
• Bueno O. F., Brandt E. B., Rothenberg M. E., Molkentin J. D. Defective T cell development and function in calcineurin A beta-deficient mice. PNAS 2002; 99: 9398–9403
   PubMed Web of Science ®Google Scholar
• Bensinger S. J., Walsh P. T., Zhang J., Carroll M., Parsons R., Rathmell J. C., et al. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 5287–5296
   PubMed Web of Science ®Google Scholar
• D'Cruz L. M., Klein L. Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 2005; 6: 1152–1159
   PubMed Web of Science ®Google Scholar
• Napoli K. L., Taylor P. J. From beach to bedside: History of the development of sirolimus. Ther Drug Monit 2001; 23: 559–586
   PubMed Web of Science ®Google Scholar
• Gao W., Lu Y., El-Essawy B., Oukka M., Kuchroo V. K., Strom T. B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007; 7: 1722–1732
   PubMed Web of Science ®Google Scholar
• Battaglia M., Stabilini A., Roncarolo M. G. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 2005; 105: 4743–4748
   PubMed Web of Science ®Google Scholar
• Hara M., Kingsley C. I., Niimi M., Read S., Turvey S. E., Bushell A. R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789–3796
   PubMed Web of Science ®Google Scholar
• Graca L., Cobbold S. P., Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641–1646
   PubMed Web of Science ®Google Scholar
• Wood K. J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199–210
   PubMed Web of Science ®Google Scholar
• Salama A. D., Najafian N., Clarkson M. R., Harmon W. E., Sayegh M. H. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643–1651
   PubMedGoogle Scholar
• Segundo D. S., Ruiz J. C., Izquierdo M., Fernández-Fresnedo G., Gómez-Alamillo C., Merino R., et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+ CD25+ Foxp3+ regulatory T cells in renal transplant recipients. Transplantation 2006; 82: 550–557
   PubMed Web of Science ®Google Scholar
• Noris M., Casiraghi F., Todeschini M., Cravedi P., Cugini D., Monteferrante G., et al. Regualtory T cells and T cell depletion: Role of immunosuppressive drugs. J Am Soc Nephrol 2007; 18: 1007–1018
   PubMed Web of Science ®Google Scholar
• Ruggenentic P., Perico N., Gotti E., Cravedi P., D'Agati V., Gagliardini E., et al. Sirolimus versus cylosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury. Transplantation 2007; 84: 956–964
   Google Scholar
• Salama A. D., Najafian N., Clarkson M. R., Harmon W. E., Sayegh M. H. Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643–1651
   PubMedGoogle Scholar
• Korczak-Kowalska G., Wierzbicki P., Bocian K., Klosowska D., Niemczyk M., Wyzgal J., et al. The influence of immunosuppressive therapy on the development of CD4+ CD25+ T cells after renal transplantation. Transplant Proc 2007; 39: 2721–2723
   PubMed Web of Science ®Google Scholar
• San Segundo D., Ruiz J. C., Fernandez-Fresnedo G., Izquierdo M., Gómez-Alamillo C., Cacho E., et al. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. Transplant Proc 2006; 38: 2391–2393
   Google Scholar
• Hariharan S., Johnson C. P., Bresnahan B. A., Taranto S. E., McIntosh M. J., Stablein D., et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605–612
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche H. U., Schold J. D., Srinivas T. R., Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378–383
   PubMed Web of Science ®Google Scholar
• Nankivell B. J., Chapman J. R. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643–654
   PubMed Web of Science ®Google Scholar
• Sayegh M. H., Remuzzi G. Clinical update: Immunosuppression minimization. Lancet 2007; 369: 1676–1678
   PubMedGoogle Scholar
• Goldrath A. W., Luckey C. J., Park R., Benoist C., Mathis D. The molecular program induced in T cells undergoing homeostatic proliferation. PNAS 2004; 101: 16885–16890
   Google Scholar
• Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184: 387–396
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Regulatory T cells: Key controllers of immunologic self tolerance. Cell 2000; 101: 455–458
   PubMed Web of Science ®Google Scholar
• Ng W. F., Duggan P. J., Ponchel F., Matarese G., Lombardi G., Edwards A. D., et al. Human CD4+ CD25+ cells: A naturally occurring population of regulatory T cells. Blood 2001; 98: 2736–2744
   PubMed Web of Science ®Google Scholar
• Khattri R., Cox T., Yasayko S. A., Ramsdell F. An essential role for scurfin in CD4+ CD25+ T regulatory cells. Nat Immunol 2003; 4: 337–342
   PubMed Web of Science ®Google Scholar
• Fontenot J. D., Rasmussen J. P., Williams L. M., Dooley J. L., Farr A. G., Rudensky A. Y. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005; 22: 329–341
   PubMed Web of Science ®Google Scholar
• Battaglia M., Stabilini A., Roncarolo M. G. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 2005; 105: 4743–4748
   PubMed Web of Science ®Google Scholar
• Cavinato R. A., Casiraghi F., Azzollini N., Cassis P., Cugini D., Mister M., et al. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 2005; 79: 1034–1039
   PubMed Web of Science ®Google Scholar
• Taylor D. O., Edwards L. B., Boucek M. M., Trulock E. P., Waltz D. A., Kack B. M., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report—2006. J Heart Lung Transplant 2006; 25: 869–879
   PubMed Web of Science ®Google Scholar
• Baan C. C., van der Mast B. J., Klepper M., Mol W. M., Peeters A. M., Korevaar S. S., et al. Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of Foxp3 in human T cells. Transplantation 2005; 80: 110–117
   PubMedGoogle Scholar
• Shevach E. M. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 2006; 25: 195–201
   PubMed Web of Science ®Google Scholar
• Bluestone J. A., Abbas A. K. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253–257
   PubMed Web of Science ®Google Scholar
• Scheffold A., Murphy K. M., Hofer T. Competition for cytokines: Treg cells take all. Nat Revs Immunol 2007; 8: 1285–1287
   Google Scholar
• Maynard C. L., Harrington L. E., Janowski K. M., Oliver J. R., Zindl C. L., Rudensky A. Y., et al. Regulatory T cells expressing interleukin 10 development from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 2007; 8: 931–941
   PubMed Web of Science ®Google Scholar
• Strauss L., Whiteside T. L., Knights A., Bergmann C., Knuth A., Zippelius A. Selective survival of naturally occurring human CD4+CD25+ Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 2007; 178: 320–329
   PubMed Web of Science ®Google Scholar
• Valmori D., Tosello V., Souleimanian N. E., Godefroy E., Scotto L., Weng Y., et al. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol 2006; 177: 944–949
   PubMed Web of Science ®Google Scholar
• Basu S., Golovina T., Mikheeva T., June C. H., Riley J. L. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 2008; 180: 5794–5798
   Google Scholar
• Demirkiran A., Hendrikx T. K., Baan C. C., van der Laan L. J. Impact of immunosuppressive drugs on CD4+CD25+ Foxp3+ regulatory T cells: Doer in vitro evidence translate to the clinical setting?. Transplantation 2008; 85: 783–789
   PubMed Web of Science ®Google Scholar